Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial

Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.
    Difference
    0.8%
    Check dated 2025-07-04T01:30:46.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.6%
    Check dated 2025-06-19T18:15:26.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T08:07:17.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:43:59.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:11.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version of the study on Mucopolysaccharidosis IVA (Morquio A Syndrome), including the removal of outdated treatment information and the addition of new study details. Notably, the enzyme replacement therapy BMN 110 is now highlighted as a potential treatment option.
    Difference
    60%
    Check dated 2025-04-16T02:07:29.000Z thumbnail image

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.